Home > National Drug Code (NDC) > Carbidopa and Levodopa

Carbidopa and Levodopa - 51079-923-20 - (carbidopa and levodopa)

Alphabetical Index


Drug Information of Carbidopa and Levodopa

Product NDC: 51079-923
Proprietary Name: Carbidopa and Levodopa
Non Proprietary Name: carbidopa and levodopa
Active Ingredient(s): 50; 200    mg/1; mg/1 & nbsp;   carbidopa and levodopa
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Carbidopa and Levodopa

Product NDC: 51079-923
Labeler Name: Mylan Insitutional Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075091
Marketing Category: ANDA
Start Marketing Date: 20120525

Package Information of Carbidopa and Levodopa

Package NDC: 51079-923-20
Package Description: 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-923-20) > 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (51079-923-01)

NDC Information of Carbidopa and Levodopa

NDC Code 51079-923-20
Proprietary Name Carbidopa and Levodopa
Package Description 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-923-20) > 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (51079-923-01)
Product NDC 51079-923
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name carbidopa and levodopa
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20120525
Marketing Category Name ANDA
Labeler Name Mylan Insitutional Inc.
Substance Name CARBIDOPA; LEVODOPA
Strength Number 50; 200
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA]

Complete Information of Carbidopa and Levodopa


General Information